Axcess Global Sciences, LLC v. Naturelo Premium Supplements, LLC
Infringement action filed 15 Jan 2026 in the United States District Court for the District of Delaware and closed 2 Apr 2026, with US11241403B2 asserted. Recorded basis of termination: voluntary dismissal.
Case record
- Patent involved
- US11241403B2
- Application no.
- US17/198634
- Case no.
- 1:26-cv-00047
- Verdict cause
- Infringement action
- Court
- D. Del.
- Court level
- District Court
- Case region
- Delaware
- Chief judge
- William C. Bryson
- Trial level
- First instance
- Filed – Closed
- 15 Jan 2026 – 2 Apr 2026
- Duration
- 77 days
- Basis of termination
- Voluntary dismissal
- Products & marks
- Beta-hydroxybutyrate mixed salt compositions and methods of use
- Validity challenges
- None recorded
Check this patent against your own product
Prior art, claim scope, infringement exposure and design-around routes. Every answer cites the records behind it.
Get an FTO claim chart- 01Ranked prior artEvery hit source-linked
- 02Claim-level comparisonAgainst your own product
- 03Legal statusAcross 174 jurisdictions
Beta-hydroxybutyrate mixed salt compositions and methods of use
Ketogenic compositions including a plurality of beta-hydroxybutyrate (BHB) salts are formulated to induce or sustain ketosis in a subject to which the ketogenic compositions are administered. The BHB mixed salt is formulated to provide a biologically balanced set of cationic electrolytes and avoid detrimental health effects associated with imbalanced electrolyte ratios. A ketogenic composition includes BHB salts selected from sodium, potassium, calcium, and magnesium salts. The BHB composition may also include transition metal cations (e.g., zinc or iron), one or more BHB-amino acid salts, a short-, medium-, or long-chain fatty acid source, vitamins, minerals, flavorants, or other excipients.
- Legal status
- Active
- Granted
- 8 Feb 2022
- Earliest priority
- 11 Mar 2016
- Est. expiry
- 9 Mar 2037
- Validity challenges
- None recorded
- Licences recorded
- None recorded
- Inventors
- MILLET, GARY
- Classification
- A61K31/19A61K31/593A61K47/14A61P3/00A23L33/12A61K9/00A61K47/10A61K9/02A61K9/20A23L33/175A61K9/14A61K9/48A23L33/16
- Prosecution counsel
- Workman Nydegger
- Examiner
- RICCI, CRAIG D
Parties of record
Axcess Global Sciences, LLC
- Core tech
- A61K31/19A61K31/593A61K47/14A61P3/00
- Counsel
- Andrew Mark Moshos · Bindu Ann George Palapura · Brian N. Platt · David Ellis Moore
- Firm
- Potter Anderson & Corroon, LLP
Naturelo Premium Supplements, LLC
- Core tech
- Not recorded
- Counsel
- Not recorded
- Firm
- Not recorded
Counsel of record
| Attorney | For | Role |
|---|---|---|
| Andrew Mark Moshos | Axcess Global Sciences, LLC | Plaintiff |
| Bindu Ann George Palapura | Axcess Global Sciences, LLC | Plaintiff |
| Brian N. Platt | Axcess Global Sciences, LLC | Plaintiff |
| David Ellis Moore | Axcess Global Sciences, LLC | Plaintiff |
Basis of termination
From the record · verbatim“Plaintiff Axcess Global Sciences, LLC (“AGS” or “Plaintiff”) hereby provides notice of its voluntary dismissal, as follows: Plaintiff and Defendant Naturelo Premium Supplements, LLC (“Defendant”) have settled the above-styled litigation pursuant to the terms and conditions of an executed Settlement Agreement between them. Pursuant to Federal Rule of Civil Procedure 41(a)(1)(A)(i) and the Settlement Agreement between them, Plaintiff hereby files this notice of voluntary dismissal with prejudice. No party has filed or served an answer or a motion for summary judgment. 3. Plaintiff and Defendant jointly request that the Court retain jurisdiction to enforce the terms of the Settlement Agreement between them.”
Case 1:26-cv-00047 · D. Del. · closed 2 April 2026
Related cases
Three questions this record usually leads to. Each one runs against the full litigation and patent corpus, and cites what it finds.
Frequently asked questions
What is case 1:26-cv-00047?
1:26-cv-00047 is a patent infringement action brought by Axcess Global Sciences, LLC against Naturelo Premium Supplements, LLC, filed on 15 Jan 2026 in the United States District Court for the District of Delaware. The case closed on 2 April 2026.
Which patent was asserted in 1:26-cv-00047?
US11241403B2 (“Beta-hydroxybutyrate mixed salt compositions and methods of use”), assigned to AXCESS GLOBAL SCIENCES, LLC, currently active. The record also lists Beta-hydroxybutyrate mixed salt compositions and methods of use.
How was case 1:26-cv-00047 terminated?
The recorded basis of termination is voluntary dismissal. The termination text reads: “Plaintiff Axcess Global Sciences, LLC (“AGS” or “Plaintiff”) hereby provides notice of its voluntary dismissal, as follows: Plaintiff and Defendant Naturelo Premium Supplements, LLC (“Defendant”) have settled the above-styled litigation pursuant to the terms and conditions of an executed Settlement Agreement between them. Pursuant to Federal Rule of Civil Procedure 41(a)(1)(A)(i) and the Settlement Agreement between them, Plaintiff hereby files this notice of voluntary dismissal with prejudice. No party has filed or served an answer or a motion for summary judgment. 3. Plaintiff and Defendant
What does dismissal with prejudice mean?
A dismissal with prejudice permanently ends the claims that were filed, so the same claims cannot be brought again against that defendant. It is the usual form when the parties have settled.
How long did case 1:26-cv-00047 take?
77 calendar days, from filing on 15 Jan 2026 to closure on 2 April 2026.
Who were the attorneys and the judge in 1:26-cv-00047?
Chief Judge William C. Bryson presided. Andrew Mark Moshos, Bindu Ann George Palapura, Brian N. Platt and David Ellis Moore are recorded as counsel for plaintiff Axcess Global Sciences.
Disclaimer. This page reproduces publicly available court docket data for case 1:26-cv-00047 and is provided for general information and reference only. It is not legal advice and must not be relied upon as such.
Docket data has limits. Records are drawn from a snapshot and may lag the live docket. Sealed filings, amended complaints, counterclaims and post-closure motions may not be reflected. Party names, attorney names and firm affiliations are reproduced as recorded and may contain omissions. Where a field is absent from the record, this page marks it as not recorded rather than inferring a value.
No characterisation of the parties or the outcome. This page reports what the record contains. Nothing here should be read as an assertion that any party infringed, that any patent is valid or invalid, that any settlement occurred, or that any party prevailed.
No FTO or validity opinion. Nothing on this page constitutes a freedom-to-operate, novelty, validity or infringement opinion. Any decision touching a live patent dispute should be verified independently and reviewed with qualified patent counsel.